The WFS1/activating transcription factor 4 (ATF4)/zinc transporter 3 (ZNT3) signaling axis is implicated in palmitate-induced apoptosis, which is associated with obesity and depression, and the drug riluzole can target this axis to maintain zinc homeostasis [402]. Here, WFS1 is linked to obesity disorder.